Renal failure after anti-D globulin treatment of idiopathic thrombocytopenic purpura

Pediatric Nephrology

Volumn 17, Issue 2, 2002, Pages 91-96

  Kees Folts, Deborah ^a   Abt, Arthur B ^a   Domen, Ronald E ^a   Freiberg, Andrew S ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Acute renal failure; Anti D globulin; Hemoglobinuria; Idiopathic thrombocytopenic purpura; Intravascular hemolysis; Pigment nephropathy

Indexed keywords

CREATINE KINASE; CREATININE; DIPHENHYDRAMINE; FUROSEMIDE; HEMOGLOBIN; LACTATE DEHYDROGENASE; MANNITOL; METHYLPREDNISOLONE SODIUM SUCCINATE; NITROGEN; PARACETAMOL; RHESUS D ANTIBODY; SODIUM CHLORIDE; UREA;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CHILL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; DYSPNEA; EPSTEIN BARR VIRUS; FEMALE; FEVER; HEMODIALYSIS; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTRAVASCULAR HEMOLYSIS; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; MALE; NAUSEA; OLIGURIA; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; SERODIAGNOSIS; VIRUS IDENTIFICATION; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HEMOLYSIS; HUMANS; INFANT; KIDNEY FAILURE, ACUTE; MIDDLE AGED; PURPURA, THROMBOCYTOPENIC; RHO(D) IMMUNE GLOBULIN;

EID: 0036939778     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-001-0763-4     Document Type: Article

References (23)

1. Harrington W, Minnich V, Hollingsworth JW, Moore CV (1951) Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 38:1-10
2. George JN, El-Harake MA, Aster RH (1996) Thrombocytopenia due to enhanced destruction by immunologic mechanisms. In: Beutler E, Lichtman MA, Coller BS, Kipps T (eds) Williams hematology, vol 5. McGraw-Hill, New York, pp 1315-1355
3. Pipp ML, Means ND, Sixbey JW, Morris KL, Gue CL, Baddour LM (1997) Acute Epstein-Barr virus infection complicated by severe thrombocytopenia. Clin Infect Dis 25:1237-1239
4. Ballem P, Belzberg A, Devine D, Lyster D, Spruston B, Chambers H, Doubroff P, Mikulash K (1992) Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection. N Engl J Med 327:1779-1784
5. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88:3-40
6. Bithell TC (1993) Thrombocytopenia caused by immunologic platelet destruction: idiopathic thrombocytopenic purpura, drug-induced thrombocytopenia and miscellaneous forms. In: Lee G, Bithell T, Foerster J, Athens J, Lukens J (eds) Wintrobe's clinical hematology, vol 2. Lea & Febiger, Philadelphia, PA, pp 1329-1355
7. Fehr J, Hofman V, Kappeler U (1982) Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin. N Engl J Med 306: 1254-1258
8. Salama A, Kiefel V, Amberg R, Mueller-Eckhart C (1984) Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-RhO(d)). Blut 49:29-35
9. Salama A, Mueller-Eckhardt C, Kiefel V (1983) Effect of intravenous immunoglobulin in immune thrombocytopenia. Lancet 2:193-95
10. Freiberg A, Mauger D (1998) Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children. Semin Hematol 35 Suppl 1:23-27
11. Hong F, Ruiz R, Price H, Griffiths A, Malinoski F, Woloski M (1998) Safety profile of WinRho anti-D. Semin Hematol 35 Suppl 1:9-13
12. Gaines AR (2000) Acute onset hemoglobinemia and/or hemoglobinuria and sequelae following Rho(D) immune globulin intravenous administration in immune thrombocytopenic purpura patients. Blood 95:2523-2529
13. Simpson KN, Coughlin CM, Eron J, Bussel JB (1998) Idiopathic thrombocytopenic purpura: treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy. Semin Hematol 35 Suppl 1:58-64
14. Henney JE (1999) Continuing shortage of IGIV. JAMA 282:1613
15. Schiavotto C, Ruggeri M, Rodeghiero F (1993) Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature. Haematologica 78:35-40
16. Cayco AV, Perazella MA, Hayslett JP (1997) Renal insufficiency after intravenous immune globulin therapy: a report of two cases and an analysis of the literature. J Am Soc Nephrol 8:1788-1794
17. Hansen-Schmidt S, Silomon J, Keller F (1996) Osmotic nephrosis due to high-dose immunoglobulin therapy containing sucrose (but not with glycine) in a patient with immunoglobulin A nephritis. Am J Kidney Dis 28:451-453
18. Cangene Corporation (2000) Rho(D) immune globulin intravenous (human) WinRho SDF (package insert). Winnipeg, Manitoba, Canada
19. Carter RL (1964) Platelet levels in infectious mononucleosis. Blood 25:817-821
20. Shurin SB (1979) Infectious mononucleosis. Pediatr Clin North Am 26:315-332
21. Friedman BI, Libby R (1986) Epstein-Barr virus infection associated with rhabdomyolysis and acute renal failure. Clin Pediatr 25:228-229
22. Scaradavou A, Woo B, Woloski BMR, Cunningham-Rundles S, Ettinger LJ, Aledort LM, Bussel JB (1997) Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients. Blood 89:2689-2700
23. Brewer T, Colditz GA (1999) Postmarketing surveillance and adverse drug reactions: current perspectives and future needs. JAMA 281:824-829